Champions Oncology, Inc., was incorporated under the laws of the State of Delaware on June 4, 1985. The company is a technology-enabled research organization dedicated to creating transformative technology solutions for drug discovery and development. The company's research center consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarkers and data platforms are designed to facilitate drug discovery and development at lower cost and faster speed. These include in vivo studies that rely on implanting multiple tumors in mice and testing treatments of interest to these tumors. The Company is engaged in the development and sales of advanced technology solutions and products, personalizing the development and use of oncology drugs through their Translational Oncology Solutions (" TOS "). The technology includes computing-based discovery platforms, unique oncology software solutions, and innovative and proprietary experimental tools such as in vivo, in vitro and biomarker platforms.
